Abiomed INC ABIOMED ORD SHS
Abiomed INC ABIOMED ORD SHS/ US0036541003 /
0H7S
|
2022-12-21 6:56:16 PM
|
Chg.
-
|
Volume |
Bid6:00:09 AM |
Ask6:00:09 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
380.7907USD
|
-
|
110
Turnover: 3,807.3628 |
-Bid Size: - |
-Ask Size: - |
17.18 bill.USD |
- |
127.01 |
Business description
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support. The products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart.
Management board & Supervisory board
| CEO |
| Michael R. Minogue |
| Management board |
| Todd A. Trapp, Andrew J. Greenfield, Chuck A. Simonton, Dr. Thorsten Siess, Karen Mahoney, Laxmi Peri, Marc Began, Matt Plano |
| Supervisory board |
| Michael R. Minogue, Chris Van Gorder, Dorothy E. Puhy, Dr. Myron L. Rolle, Dr. Paula A. Johnson, Eric Rose, Jeannine Rivet, Martin P. Sutter, Paul G. Thomas, W. Gerald Austen |
Company data
| Name: |
Abiomed Inc. |
| Address: |
22 Cherry Hill Drive,Danvers, Massachusetts 01923, USA |
| Phone: |
+1-978-646-1400 |
| Fax: |
+1-978-777-8411 |
| E-mail: |
-
|
| Internet: |
www.abiomed.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
03-31 |
| Free Float: |
73.60% |
| IPO date: |
- |
Investor relations
| Name: |
Todd Trapp |
| IR phone: |
+1-978-646-1680 |
| IR Fax: |
- |
| IR e-mail: |
ir@abiomed.com
|
Main Shareholders
| Freefloat |
|
73.60% |
| The Vanguard Group, Inc. |
|
10.60% |
| Blackrock, Inc. |
|
9.10% |
| Baillie Gifford & Co |
|
6.70% |
| Others |
|
0.00% |
